Advanced solid tumors, Breast Cancer research hub

A Phase 1 Study of ATV-1601, in Patients with Advanced Cancer that have AKT1 E17K Mutations

This early-stage study is looking at a new medicine called ATV-1601. It's for adults with advanced cancers, especially breast cancer, that have a specific genetic change called an AKT1 E17K mutation. The main goal is to see if the medicine is safe and how it works in people.